Palantir's Blowout Quarter Meets a Wall of Insider Selling — and a Debate About Price
Published on 08/08/2026 at 06:25 | Redaktion boerse-global.de
The numbers coming out of Palantir Technologies this week were the kind that usually end arguments. Revenue up 93 percent year over year. A US commercial business growing at 149 percent. Guidance raised for the second time in as many quarters. And yet, the most telling detail of the week may not be in the earnings release at all — it's in the regulatory filings showing who was selling stock while the shares were soaring.
Palantir reported second-quarter 2026 revenue of $1.935 billion, with the US commercial segment surging to $764 million. GAAP net income hit $1.062 billion, or $0.41 per share, comfortably ahead of the $0.34 consensus estimate. The company's "Rule of 40" score — a metric combining growth and profitability where 40 is already considered excellent — came in at 155 percent. Management lifted full-year revenue guidance to a range of $8.150 billion to $8.158 billion and projected adjusted free cash flow of $4.5 billion to $4.7 billion. The quarter also produced 220 deals worth at least $1 million, including 73 above $10 million, with total contract value of $3.373 billion.
The market's response was immediate and emphatic. The stock closed Friday at €148.84, up 9.88 percent on the day and 39.47 percent over seven trading days. Yet even after that surge, the shares remain 17.30 percent below their 52-week high — meaning the rally has only recovered a portion of the earlier drawdown rather than reclaiming prior records.
Insider sales during the rally raise questions
What gives some investors pause is the timing of insider activity. Regulatory filings show CEO Alex Karp and several key directors sold more than $150 million worth of stock during the post-earnings rally. Director Lauren Elaina Friedman Stat disposed of 3,032 shares, while Cathie Wood's Ark Invest fund offloaded 39,233 shares worth roughly $4.93 million in the session following the results.
Insider selling alone is rarely a red flag — executives diversify, funds take profits. But the concentration of sales into the strongest price move in months creates an awkward juxtaposition with the public enthusiasm. Director Alexander Moore, for instance, sold 20,000 shares on August 1 under a pre-arranged trading plan for about $3.09 million, following an earlier disposal of 16,000 shares at an average price of $134.05 on July 17.
Institutional interest tells a different story. Montchanin Asset Management disclosed a new position on August 1, and the New York State Common Retirement Fund held roughly 2.37 million Palantir shares as of July 29. The two signals — insider selling and institutional accumulation — aren't mutually exclusive; they simply reflect different time horizons.
Just as investors weigh competing signals about Palantir's future, employers face their own compliance scrutiny — and the cost of getting it wrong can be severe. A free toolkit with 41 ready-to-use templates and checklists helps you document workplace risks properly and stay on the right side of UK health and safety law. Download the free Risk Assessment Toolkit
Analysts split between conviction and caution
The analyst community has largely endorsed the operational story, though with varying degrees of enthusiasm. Deutsche Bank's Brad Zelnick upgraded the stock from Hold to Buy on Monday, keeping a $200 price target and describing Palantir as a "time traveler" in the AI sector following an "extraordinary" quarter. A Seeking Alpha analyst subsequently raised his target from $183 to $196, citing accelerating momentum for the Artificial Intelligence Platform and adjusted free cash flow margins above 60 percent.
Others have tempered their optimism. Citigroup trimmed its target from $225 to $200, citing broader compression in market valuations, while Oppenheimer and William Blair maintained their positive stances — the latter noting the results undercut concerns about competition from OpenAI and Anthropic. The most notable pushback came from Pythia Research, which downgraded Palantir from Strong Buy to Buy not on fundamentals but on valuation, arguing the rally had consumed much of the remaining upside.
A tax controversy adds a secondary layer
Separately, a report from the Centre for International Corporate Tax Accountability and Research, published via The Guardian, drew attention to Palantir's effective global tax rate of just 1.4 percent in 2025 despite record profits, with no US federal income tax paid. The finding doesn't alter the operational growth story, but it adds a dimension to the public perception of a company now squarely in the political and regulatory spotlight.
The tension at the heart of the rally
The core dilemma is straightforward: the operational performance is exceptional by almost any measure, but the stock's trajectory has created a gap between price and fundamentals that even sympathetic observers acknowledge. The adjusted operating margin of 62 percent — up 1,600 basis points from 46 percent a year earlier — suggests growth isn't coming at the expense of profitability, and the raised guidance indicates management's confidence in sustaining the pace.
Yet the insider sales, the valuation-driven downgrade, and the fact that the stock still sits well below its peak all point to a more complicated picture than the headline numbers suggest. Investors buying here are paying for an excellent business — but they're also buying into a situation where even the company's own leadership appears to be realizing gains rather than adding to positions. The next test comes with the third-quarter report, tentatively scheduled for November 2, which will show whether Palantir can maintain this trajectory — and whether the market's enthusiasm can survive another round of scrutiny.
